Daniel J. O'Connor

Supporter
DISC Type : s

Chief Executive Officer at Jubilant Therapeutics Inc

Pennington, New Jersey, United States

Overview

Daniel J. O’Connor is a 25+ year biotech executive specializing in oncology drug development and corporate turnarounds. As CEO of companies like Jubilant Therapeutics and Ambrx, he has a record of scaling clinical-stage enterprises, highlighted by the $2 billion acquisition of Ambrx under his leadership. He holds a J. D. from Penn State Dickinson Law.

Outside of his corporate roles, Daniel is a U. S. Marine Corps veteran who served as a Captain during Operation Desert Shield. A second-generation Irish American, he values home and family, is married with three sons, and mentions enjoying a cold beer at the end of the day.

Unique fact: Before his career in biotech, he served as a criminal prosecutor in Somerset County, New Jersey.

Personality Overview

Thoughtful In Approach

Procedural

Social Proof Driven

They maintain good relationships with everyone, internally and externally.  They are motivated by the potential impact of their decision on the organization. They are unlikely to become strong champions as they don't prefer pushing other people.

Topics They Care About

Biotech Turnarounds
He has a reputation for transforming underperforming biotechs, taking Ambrx from a $40M valuation to a $2B acquisition and bringing Advaxis back from near-bankruptcy.
Oncology Drug Development
His entire career is focused on oncology, from his early involvement with Erbitux at ImClone to leading multiple clinical-stage cancer therapy companies.
Antibody Drug Conjugates
A key focus during his recent, successful tenure as CEO of Ambrx, where he advanced the development of next-generation ADCs for cancer treatment.

Media Appearances

Daniel has no verified media appearances

Work History

12-2025
Chief Executive Officer at Jubilant Therapeutics Inc
11-2022 - 3-2024
Chief Executive Officer and Director at Ambrx
6-2021 - 12-2022
Co-Founder, CEO and Director at Larkspur Health Acquisition Corp.
9-2017 - 6-2021
President, CEO and Director at OncoSec
1-2013 - 7-2017
President, CEO and Director at Advaxis, Inc.

Education

1992 - 1995
Doctor of Law (JD) from Penn State Dickinson Law
1984 - 1987
Bachelor of Arts (B.A.) from Boston University

More Information

Social Presence :

Prographics :

Exp : 10 Location : Pennington, New Jersey, United States Job Level : Leadership Designation : Chief Executive Officer at Jubilant Therapeutics Inc
URL has been copied!

Insights For Selling To Daniel J.

During A Call Or A Meeting

DO's

  • Use phrases like ‘others say that’, ‘zero risk in’, ‘seen proof of’ etc.
  • Talk about refund and cancellation policy if the need arises
  • Engage other key stakeholders on their side and leverage if they approve of your product

DONT's

  • Don’t don the salesperson avatar, be the friendly advisor instead
  • Don’t use phrases like ‘there might be’, ‘we haven’t yet’, ‘latest technology’ etc.
  • Avoid saying anything that sounds like a risky proposition

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Daniel J. is

  • Low-risk, go-ahead from other stakeholders and successful evaluation as per process matter the most to them.
  • Will you ever get a clear answer from Daniel J.

  • They don’t say no very often, and can take you around in circles sometimes.

Insights For Deal Planning

    How fast (or slow) will Daniel J. move?

  • They do not like to rush and can be quite slow in their decision making.

  • Can Daniel J. take some risk or not?

  • They have little risk-appetite and prefer to take decisions that others support.

You And Daniel J.

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.